Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 261013

Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.


Oršolić, Nada; Golemović, Mirna; Quintas-Cardama, A; Scappini, Barbara; Manshouri, Taghi; Chandra, Joya; Bašić, Ivan; Giles, Francis; Kantarjian, Hagop; Verstovsek, Srđan
Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells. // Cancer Science, 97 (2006), 9; 952-960 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 261013 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.

Autori
Oršolić, Nada ; Golemović, Mirna ; Quintas-Cardama, A ; Scappini, Barbara ; Manshouri, Taghi ; Chandra, Joya ; Bašić, Ivan ; Giles, Francis ; Kantarjian, Hagop ; Verstovsek, Srđan

Izvornik
Cancer Science (1347-9032) 97 (2006), 9; 952-960

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
adaphostin; Bcr/Abl; cytotoxicity; CML; AML

Sažetak
Adaphostin is a tyrphostin that was designed to inhibit Bcr/Abl tyrosine kinase by altering the binding site of peptide substrates rather than that of adenosine triphosphate, a known mechanism of imatinib mesylate (IM). However, it has been shown that adaphostin-mediated cytotoxicity is dependent on oxidant production and does not require Bcr/Abl. We have tested adaphostin against both Philadelphia chromosome (Ph)-positive (K562, KBM5, KBM5-R [IM resistant KBM5], KBM7, and KBM7-R [IM-resistant KBM7]) and Ph-negative (OCI/AML2 and OCI/AML3) cells, and against cells from patients with chronic myeloid leukemia (CML) and acute myeloid leukemia (AML). Adaphostin significantly inhibited growth of all cell lines (50% inhibition of cell proliferation [IC50] 0.5-1 microM) except K562 (IC50 13 microM). Ph-positive IM-resistant cell lines showed significant cross resistance to adaphostin. Simultaneous or sequential treatment with adaphostin and IM did not exert a synergistic effect in any KBM line. Adaphostin induced superoxide and apoptosis in a dose-dependent and time-dependent fashion in both Ph-positive and Ph-negative cells. Adaphostin selectively inhibited colony growth of cells from CML (IM-sensitive and IM-resistant) and AML patients. Analysis of tyrosine phosphorylated proteins after treatment with adaphostin revealed alternate effects in different cells consistent with the modulation of multiple targets. In conclusion, adaphostin showed significant and selective activity against CML and AML cells and its development for clinical testing is warranted.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
0214201

Ustanove:
Prirodoslovno-matematički fakultet, Zagreb,
Klinički bolnički centar Zagreb


Citiraj ovu publikaciju:

Oršolić, Nada; Golemović, Mirna; Quintas-Cardama, A; Scappini, Barbara; Manshouri, Taghi; Chandra, Joya; Bašić, Ivan; Giles, Francis; Kantarjian, Hagop; Verstovsek, Srđan
Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells. // Cancer Science, 97 (2006), 9; 952-960 (međunarodna recenzija, članak, znanstveni)
Oršolić, N., Golemović, M., Quintas-Cardama, A., Scappini, B., Manshouri, T., Chandra, J., Bašić, I., Giles, F., Kantarjian, H. & Verstovsek, S. (2006) Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.. Cancer Science, 97 (9), 952-960.
@article{article, author = {Or\v{s}oli\'{c}, Nada and Golemovi\'{c}, Mirna and Quintas-Cardama, A and Scappini, Barbara and Manshouri, Taghi and Chandra, Joya and Ba\v{s}i\'{c}, Ivan and Giles, Francis and Kantarjian, Hagop and Verstovsek, Sr\djan}, year = {2006}, pages = {952-960}, keywords = {adaphostin, Bcr/Abl, cytotoxicity, CML, AML}, journal = {Cancer Science}, volume = {97}, number = {9}, issn = {1347-9032}, title = {Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.}, keyword = {adaphostin, Bcr/Abl, cytotoxicity, CML, AML} }
@article{article, author = {Or\v{s}oli\'{c}, Nada and Golemovi\'{c}, Mirna and Quintas-Cardama, A and Scappini, Barbara and Manshouri, Taghi and Chandra, Joya and Ba\v{s}i\'{c}, Ivan and Giles, Francis and Kantarjian, Hagop and Verstovsek, Sr\djan}, year = {2006}, pages = {952-960}, keywords = {adaphostin, Bcr/Abl, cytotoxicity, CML, AML}, journal = {Cancer Science}, volume = {97}, number = {9}, issn = {1347-9032}, title = {Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.}, keyword = {adaphostin, Bcr/Abl, cytotoxicity, CML, AML} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font